Quest PharmaTech Names Jeffrey Shon CEO as Madiyalakan Retires

Quest PharmaTech Inc. (QPT.V) appointed Jeffrey Shon as chief executive officer, succeeding Madi Madiyalakan, who is retiring, the Canadian biopharmaceutical company announced on September 28, 2026. Shon takes the top role at the Edmonton-based company, which develops products through investee companies and proprietary technologies, including its antibody-focused portfolio. The company did not disclose further terms of the transition or Madiyalakan's retirement date. Quest PharmaTech trades on the TSX Venture Exchange under the ticker QPT.V.